Efficacy of Autologous Bone Marrow-Derived Mesenchymal Stem Cell and Mononuclear Cell Transplantation in Type 2 Diabetes Mellitus: A Randomized, Placebo-Controlled Comparative Study-Reference-Cited by-同舟云学术

Efficacy of Autologous Bone Marrow-Derived Mesenchymal Stem Cell and Mononuclear Cell Transplantation in Type 2 Diabetes Mellitus: A Randomized, Placebo-Controlled Comparative Study

Published:2017-04 Issue:7 Volume:26 Page:471-481
ISSN:1547-3287
Container-title:Stem Cells and Development
language:en
Short-container-title:Stem Cells and Development

Author:

Bhansali Shobhit¹,Dutta Pinaki¹,Kumar Vinod²,Yadav Mukesh Kumar³,Jain Ashish⁴,Mudaliar Sunder⁵,Bhansali Shipra⁶,Sharma Ratti Ram⁴,Jha Vivekanand²,Marwaha Neelam⁴,Khandelwal Niranjan³,Srinivasan Anand⁷,Sachdeva Naresh¹,Hawkins Meredith⁸,Bhansali Anil¹

Affiliation:

1. Department of Endocrinology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

2. Department of Nephrology/Translational and Regenerative Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

3. Department of Radiodiagnosis, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

4. Department of Transfusion Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

5. Department of Medicine, University of California, San Diego, La Jolla, California.

6. Department of Experimental Medicine and Biotechnology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

7. Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

8. Division of Endocrinology and Diabetes Research and Training Center, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York.

Publisher

Mary Ann Liebert Inc

Subject

Cell Biology,Developmental Biology,Hematology

Link

https://www.liebertpub.com/doi/pdf/10.1089/scd.2016.0275

Reference35 articles.

1. Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial

2. Thiazolidinediones improve β-cell function in type 2 diabetic patients

3. Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years

4. Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study

5. Pathophysiologic Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autologous intraarterial pancreatic bone-marrow mononuclear cells infusion in T2D patients: Changes on beta-cells function, insulin resistance, and inflammatory marker;Current Research in Translational Medicine;2024-06

2. Progress and application of adipose-derived stem cells in the treatment of diabetes and its complications;Stem Cell Research & Therapy;2024-01-02

3. Enhancing the therapeutic efficacy of mesenchymal stem cell transplantation in diabetes: Amelioration of mitochondrial dysfunction-induced senescence;Biomedicine & Pharmacotherapy;2023-12

4. Freeze‐Dried Mesenchymal Stem Cells: From Bench to Bedside. Review;Advanced Biology;2023-11-21

5. Stem cells therapy for diabetes: from past to future;Cytotherapy;2023-11